pioglitazone has been researched along with dehydroepiandrosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Beltagy, K; Honda, K; Ishiko, O; Misugi, T; Ozaki, K; Tokuyama, O | 1 |
| Abruzzese, GA; Ferreira, SR; Heber, MF; Motta, AB; Velez, LM | 1 |
2 other study(ies) available for pioglitazone and dehydroepiandrosterone
| Article | Year |
|---|---|
Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
Topics: 17-Hydroxysteroid Dehydrogenases; Adjuvants, Immunologic; Animals; Chromans; Dehydroepiandrosterone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Hypoglycemic Agents; Immunohistochemistry; Insulin; Metformin; Ovary; Pioglitazone; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Testosterone; Thiazolidinediones; Troglitazone | 2006 |
Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats.
Topics: Animals; Co-Repressor Proteins; Dehydroepiandrosterone; Disease Models, Animal; Estradiol; Female; Hyperandrogenism; Inflammation Mediators; Ligands; Ovarian Follicle; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pioglitazone; PPAR gamma; Rats, Sprague-Dawley; Signal Transduction; Testosterone | 2019 |